CYTONAUT Trademark

Trademark Overview


On Monday, April 11, 2022, a trademark application was filed for CYTONAUT with the United States Patent and Trademark Office. The USPTO has given the CYTONAUT trademark a serial number of 97356387. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by SCIPIO BIOSCIENCE. The CYTONAUT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Design, installation, updating, maintenance of computer software used in connected medical devices except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software used for biological, chemical and medical analysis except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software used for medical diagnosis except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software in the medical field except sofware for evaluating and treating vision disorders; Software as a Service (SaaS) featuring software for biological, chemical and medical analysis and for medical diagnosis except sofware for evaluating and treating vision disorders; scientific and technological services, namely, scientific research and conception services, namely, design in the field of pharmaceutical, chemical, and biotechnology research, and b...
cytonaut

General Information


Serial Number97356387
Word MarkCYTONAUT
Filing DateMonday, April 11, 2022
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7066306
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesDesign, installation, updating, maintenance of computer software used in connected medical devices except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software used for biological, chemical and medical analysis except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software used for medical diagnosis except sofware for evaluating and treating vision disorders; design, installation, updating, maintenance of computer software in the medical field except sofware for evaluating and treating vision disorders; Software as a Service (SaaS) featuring software for biological, chemical and medical analysis and for medical diagnosis except sofware for evaluating and treating vision disorders; scientific and technological services, namely, scientific research and conception services, namely, design in the field of pharmaceutical, chemical, and biotechnology research, and biological, chemical and medical analysis; chemical analysis services; biological research; bacteriological research; chemical research; medical research; scientific research; scientific laboratory services;research and development of new products for third parties in the fields of biological, chemical and medical analysis and medical diagnosis; biochemical research and development; pharmaceutical, biomedical and biotechnological research and development; laboratory research, analysis, evaluation, development and clinical testing in particular conducting clinical trials for others of therapeutic, preventive and diagnostic compositions and treatments; conducting scientific and medical research for others; consulting services in the fields of pharmaceutical, chemical, and biotechnology research; chemical substances synthesis services, namely, custom design and development of chemical substances for medical, scientific, and technological applications; chemical and biological development services, namely, development of biochemical, genetic and transcriptomic assays; chemical and biological laboratory services; conducting chemical and biological analyses; customized conception in particular, custom design and development of chemical reagents

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSCIPIO BIOSCIENCE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMontrouge 92120
FR

Party NameSCIPIO BIOSCIENCE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMontrouge 92120
FR

Party NameSCIPIO BIOSCIENCE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMontrouge 92120
FR

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, May 4, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, May 1, 2023ASSIGNED TO PETITION STAFF
Tuesday, April 11, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 7, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, February 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 7, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, February 7, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2022NON-FINAL ACTION WRITTEN
Monday, December 19, 2022ASSIGNED TO EXAMINER
Friday, April 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2022NEW APPLICATION ENTERED